Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.08.11.744128

Ecological Network Inference Reveals 737 Cross-Kingdom Associations Structuring Human Microbiomes

Abstract

The human microbiome is a complex, multikingdom ecosystem where bacteria and fungi cohabit and interact. Despite their ecological and clinical significance, cross-kingdom dynamics remain poorly characterized due to dominant single-kingdom research approaches. To understand the principles structuring multi-kingdom microbial communities, we applied the sparse inference method SpiecEasi to 45 publicly available samples from the gastrointestinal tract, skin, and oral cavity. Bacterial (16S rRNA) and fungal (ITS) sequencing data were processed using QIIME2, managed in phyloseq, and co-occurrence networks were inferred via SpiecEasi with Meinshausen- Buhlmann estimation. To validate robustness, we employed SparCC as a secondary inference method and performed 100 bootstrap iterations. Body site stratification controlled for environmental confounders. Our analysis revealed a microbial network of 5,023 taxa (5,020 bacterial, 3 fungal) connected by 30,478 significant associations. Crucially, we identified 737 robust bacterial-fungal interkingdom interactions (689 positive, 48 negative) confirmed by both inference methods. The network exhibited sparse connectivity (density = 0.0024) and modular structure (modularity = 0.45). Hub analysis identified 15 keystone taxa, including Bacteroides uniformis and Faecalibacterium prausnitzii. Interaction patterns were body-site-specific (P < 0.001), with the gastrointestinal tract showing the highest interkingdom connectivity (385 edges). This study provides systematic evidence that bacterial-fungal interactions are abundant and integral to human microbiome architecture. The discovery of 737 cross-kingdom associations challenges the prevailing single-kingdom paradigm and advocates for an integrated multikingdom perspective. These interactions, particularly those mediated by keystone hubs, represent novel targets for microbiome-based therapeutics and diagnostics. ImportanceThis study challenges the prevailing single-kingdom paradigm in microbiome research by demonstrating that bacterial-fungal interactions are abundant and integral to human microbiome architecture. The discovery of 737 cross-kingdom associations across three body sites provides a foundational resource for understanding multikingdom microbial ecology. The identification of keystone bacterial hubs--particularly Bacteroides uniformis and Faecalibacterium prausnitzii--as central connectors in interkingdom networks opens new avenues for microbiome-based therapeutics and diagnostics. Our integrated analytical framework, combining SpiecEasi and SparCC with body site stratification, offers a robust methodological template for future cross-kingdom studies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Babaei, A., Siadat, S. D.. 2026-08-17. Ecological Network Inference Reveals 737 Cross-Kingdom Associations Structuring Human Microbiomes. https://doi.org/10.64898/2026.08.11.744128

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗